Maxim Group analyst Jason McCarthy initiated coverage with a Buy rating on Achieve Life Sciences Inc (ACHV – Research Report)
Category: Healthcare
Maxim Group Thinks Hemispherx Biopharma’s Stock is Going to Recover
Maxim Group analyst Jason McCarthy initiated coverage with a Buy rating on Hemispherx Biopharma (HEB – Research Report) yesterday and
Incyte Corp (INCY) Receives a Buy from Cowen & Co.
In a report released today, Marc Frahm from Cowen & Co. maintained a Buy rating on Incyte Corp (INCY –
William Blair Keeps a Buy Rating on Bluebird Bio (BLUE)
William Blair analyst Raju Prasad maintained a Buy rating on Bluebird Bio (BLUE – Research Report) today. The company’s shares
Cowen & Co. Sticks to Their Buy Rating for Bluebird Bio (BLUE)
In a report released today, Yaron Werber from Cowen & Co. maintained a Buy rating on Bluebird Bio (BLUE –
H.C. Wainwright Thinks Karyopharm Therapeutics’ Stock is Going to Recover
In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Karyopharm Therapeutics (KPTI – Research
Aptose Biosciences (APTO) Gets a Buy Rating from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Aptose Biosciences (APTO – Research Report) today and set a